Supplementary file 1_An umbrella meta-analysis of microbial therapy on hepatic steatosis, fibrosis, and liver stiffness in metabolic dysfunction-associated steatotic liver disease.zip
Background<p>Metabolic dysfunction-associated steatotic liver disease is considered the leading cause of chronic liver disease worldwide. By now, no confirmed medication is accessible for the treatment of MASLD. Previous studies showed the positive effects of microbial therapy, such as probiot...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Daljnji autori: | , , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|